Effect of cyclic AMP on urokinase-type plasminogen activator receptor and fibrinolytic factors in a human osteoblast-like cell line

BBA - Molecular Cell Research

Volumn 1266, Issue 1, 1995, Pages 50-56

  Nonaka, Tohgo ^a   Matsumoto, Hiroshi ^a   Shimada, Wataru ^a   Miyagi, Ichiro ^a   Okada, Kiyotaka ^a   Fukao, Hideharu ^a   Ueshima, Shigeru ^a   Kikuchi, Hiraku ^a   Tanaka, Seisuke ^a   Matsuo, Osamu ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

(Human osteoblast like cell); Cyclic AMP (cAMP); Urokinase type plasminogen activator (u PA); Urokinase type plasminogen activator receptor (u PAR)

Indexed keywords

BUCLADESINE; BUTYRIC ACID; CYCLIC AMP; FORSKOLIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR; PROUROKINASE;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FIBRINOLYSIS; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL;

BUCLADESINE; BUTYRIC ACID; BUTYRIC ACIDS; CELL LINE; CYCLIC AMP; FIBRINOLYSIS; FORSKOLIN; HUMAN; OSTEOBLASTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, CELL SURFACE; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; URINARY PLASMINOGEN ACTIVATOR;

EID: 0028954925     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-4889(94)00220-9     Document Type: Article

References (30)

1. Soluble factors released by the target organ enhance the urokinase-type plasminogen activator activity of metastatic tumor cells